← Scroll for more →
Financial Statements — MANE
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Cash & Equivalents | 319.33 | 168.41 |
| Total Current Assets | 824.75 | 397.07 |
| Property, Plant & Equipment | 0.04 | 0.02 |
| Total Non-current Assets | 0.99 | 0.29 |
| Total Assets | 825.74 | 397.36 |
| Accounts Payable | 5.92 | 1.07 |
| Total Current Liabilities | 11.69 | 6.72 |
| Total Non-current Liabilities* | 0.43 | 0.00 |
| Total Liabilities | 12.12 | 6.72 |
| Retained Earnings | (174.15) | (150.65) |
| Total Stockholder Equity | 813.61 | 390.64 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Research & Development | 18.61 | 20.93 |
| Selling, General & Admin | 10.95 | 8.94 |
| Total Operating Expenses | 29.55 | 29.86 |
| Operating Income | (29.55) | (29.86) |
| Pretax Income | (23.50) | (27.23) |
| Tax Provision | 0.00 | 0.00 |
| Net Income | (23.50) | (27.23) |
| Basic EPS | (0.58) | (1.32) |
| Diluted EPS | (0.58) | (1.32) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | (14.49) | (21.17) |
| Capital Expenditures | 0.02 | 0.00 |
| Free Cash Flow* | (14.51) | (21.17) |
| Investing Cash Flow | (277.29) | (101.30) |
| Financing Cash Flow | 442.70 | 269.11 |
← Scroll for more columns →
* Derived from reported values